Susquehanna International Group, LLP Affimed N.V. Call Options Transaction History

Susquehanna International Group, LLP

$560 Billion
Q3 2024

Call Options

18 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2022 Feb 14, 2023	SELL	$1.1 - $2.45 $14,960 - $33,320	-13,600 Reduced 9.68%	126,900 $157,000
Q3 2022 Nov 14, 2022	SELL	$1.96 - $3.32 $80,752 - $136,784	-41,200 Reduced 22.67%	140,500 $289,000
Q2 2022 Aug 15, 2022	BUY	$2.27 - $4.86 $92,843 - $198,774	40,900 Added 29.05%	181,700 $503,000
Q1 2022 May 16, 2022	BUY	$3.69 - $5.65 $46,125 - $70,625	12,500 Added 9.74%	140,800 $615,000
Q4 2021 Feb 14, 2022	BUY	$5.37 - $7.07 $241,113 - $317,443	44,900 Added 53.84%	128,300 $708,000
Q3 2021 Nov 15, 2021	SELL	$5.54 - $7.51 $39,334 - $53,321	-7,100 Reduced 7.85%	83,400 $515,000
Q2 2021 Aug 11, 2021	SELL	$7.78 - $11.4 $494,030 - $723,900	-63,500 Reduced 41.23%	90,500 $769,000
Q1 2021 May 17, 2021	BUY	$5.12 - $8.48 $715,776 - $1.19 Million	139,800 Added 984.51%	154,000 $1.22 Million
Q4 2020 Feb 16, 2021	SELL	$3.16 - $7.03 $106,176 - $236,208	-33,600 Reduced 70.29%	14,200 $83,000
Q3 2020 Nov 16, 2020	SELL	$3.26 - $4.73 $200,490 - $290,895	-61,500 Reduced 56.27%	47,800 $162,000
Q2 2020 Aug 14, 2020	BUY	$1.58 - $4.63 $127,190 - $372,715	80,500 Added 279.51%	109,300 $504,000
Q4 2019 Feb 14, 2020	SELL	$2.25 - $3.07 $310,050 - $423,046	-137,800 Reduced 82.71%	28,800 $79,000
Q3 2019 Nov 14, 2019	SELL	$2.67 - $3.65 $289,695 - $396,025	-108,500 Reduced 39.44%	166,600 $490,000
Q2 2019 Aug 14, 2019	BUY	$2.6 - $4.21 $125,060 - $202,501	48,100 Added 21.19%	275,100 $790,000
Q1 2019 May 15, 2019	BUY	$3.05 - $4.34 $352,885 - $502,138	115,700 Added 103.95%	227,000 $953,000
Q3 2018 Nov 14, 2018	BUY	$1.45 - $6.15 $161,385 - $684,495	111,300 New	111,300 $484,000
Q2 2018 Aug 14, 2018	SELL	$1.65 - $2.5 $69,795 - $105,750	-42,300 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$1.25 - $2.65 $52,875 - $112,095	42,300 New	42,300 $78,000

Others Institutions Holding AFMD

# of Institutions

Shares Held

1.09M

Call Options Held

Put Options Held

View Full List

About Affimed N.V.

Ticker AFMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 149,339,008
Market Cap $185M
Description
Affimed N.V., a clinical-stage biopharmaceutical company, focuses on discovering and developing cancer immunotherapies in the United States, Germany, and rest of Europe. Its lead product candidate is AFM13, which has completed Phase II clinical study for peripheral T-cell lymphoma; in Phase IIa clinical trial for CD30-positive lymphoma; and in P...

More about AFMD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account